Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Rating) have been assigned a consensus recommendation of “Moderate Buy” from the six research firms that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price […]